Accueil > Revue De Presse > L’Europe, l’Afrique, le Monde > Les pratiques dans les autres pays > Comparaison intéressante.....US/FR

Comparaison intéressante.....US/FR

mercredi 28 octobre 2015 - Rédaction SNP

Le quotidien de Chicago nous donne quelques informations sur les conditions de lutte contre l’Agrile du Frêne (EAB emerald ash borer).

Un point commun avec nous : le produit utilisé TREE-äge cousin très proche du REVIVE (selon nous). mise en œuvre : endothérapie.

 Des différences : rémanence double , mis en œuvre plus complexe ( deux ou trois fois plus d’injecteurs) les prix : en moyenne 160 € par traitement à comparer à notre fourchette 222€/172€

Les volumes sont considérablement supérieurs aux États-Unis. Les collectivités abondent le système à hauteur de 30 %. Don’t panic ! cela laisse une place suffisante pour une négociation tarifaire parfaitement classique. CQFD
 

Residents who are trying to save their ash trees from the deadly emerald ash borer were disappointed to hear their efforts will be stymied by a village decision to end a program that helps pay for treatments.

Officials in Arlington Heights said this week that they are ending a $57,000 program aimed at saving the last 2,000 surviving ash trees in the village.

Ed Michalski, a resident of the 2600 block of North Forrest Lane in the Northgate Five neighborhood, said Tuesday that he and fellow residents who have participated in the village’s 50/50 Cost Share program — which reimburses residents who treat their parkway ash trees to ward off the EAB – were surprised and disappointed, and plan to fight what they call a misguided decision.
"We’re not giving up yet, and the village knows we will not take ’no’ as a final answer," Michalski said. "There has got to be some way to support the homeowners that are treating their ash trees, so we’ll keep working at it."
More than 10,000 of the village’s 13,000 parkway ash trees have died and been removed since the EAB was first spotted in the village in 2011, officials said.

Michalski said about 2,500 of the remaining ash trees have been saved by residents like himself who are participating in the 50/50 Cost Share program, most of whom live in the village’s Northgate and Arlington Terrace neighborhoods.
Residents who participate in the 50/50 Cost Share program say the name of the initiative is somewhat misleading, as the typical cost to effectively protect an ash tree with TREE-age – a trunk injection product — is between $165 to $185 a treatment, while the village reimburses residents a maximum of $50. Saving an ash tree requires multiple treatments over several years to be effective.

But Arlington Heights Mayor Thomas Hayes said the 50/50 Cost Share program was never intended to become a permanent item on the village budget, and the extension was granted with the understanding that officials were doing so for residents on a one-time basis.

"This is a really good example of a public-private partnership," Hayes said. "We’ve tried to save as many trees as we could, but for some, it’s a losing battle."
Still, Michalski said the village’s EAB-fighting program has been successful in protecting more than 2,000 surviving ash trees from the pernicious green beetle. Those efforts, he said, will ensure that the ash will continue to remain a stately presence in neighborhood parkways alongside more than a dozen other species, including maple, oak, elm and ginkgo.


"I can’t believe the village is saying that spending $165 to save an ash tree is not worth it, when they spend at least $1,000 to take down an ash tree and plant a new one," Michalski said.
The loss of mature trees will be devastating, he said.
"It will take at least 20 years for the new trees to grow tall enough for our neighborhoods to get any benefits, like a canopy," Michalski said. "I’m in my 60s, so there’s a chance I won’t even be there to see it."


kcullotta@tribpub.com

Derniers articles

16 juillet, par Rédaction SNP

Adopter la Vigilance Attitude pour CRP & PA

En septembre 2017 nous vous avons signalé l’apparition de cette application lanceur d’alertes. Le démarrage n’a pas été à la hauteur de nos espérances. il faut dire que les mairies que nous avons approché pour leur dire tout (...)

15 juillet, par Rédaction SNP

REVIVE saison 2

On attendait une extension d’usage au Paysandisia, la suppression d’un adjuvant....rien de tout cela. En baptisant REVIVE II ARETOR nom commercial ( et non Terminator !) la firme a sans doute voulu s’éloigner de la notion (...)

14 juillet, par Rédaction SNP

INRA et BIOCONTROLE

Intéressante communication grand public faisant le point des recherches de l’institution sur le Biocontrole. Sont abordés les domaines :
DES ODEURS POUR LUTTER CONTRE LES RAVAGEURS
LES MACRO-ORGANISMES : DES ALLIÉS DE (...)

Edito

Edito de juin 2018

13 juillet, par Rédaction SNP

Chers amis et passionnés du palmier,
Vous connaissez l’aphorisme "le pire n’est jamais sûr" on va s’y accrocher. Pourtant le 1er septembre c’est demain date-butoir de l’utilisation du Confidor. Nous n’avons aucune nouvelle de notre demande article 53 de prorogation 120 jours de l’usage de ce produit.
On a le sentiment que les lobbys écologistes sont tellement puissants dans notre pays que rien ne peut résister à leurs péremptoires (...)